🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 22 of 30

  1. US 7713973

    Kinase inhibitors

    Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7714009

    Nitrogen-containing fused heterocyclic compounds

    Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7700128

    Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7700361

    Secretory or membrane protein expressed in skeletal muscles

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7696218

    Substituted 1,3-dialkyl-2,4-dioxo-6-(arylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7687625

    Dipeptidyl peptidase inhibitors

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7687638

    Dipeptidyl peptidase inhibitors

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7671174

    Ligand to GPR8

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7662380

    ZAQ ligand-1 antibodies and uses thereof

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7662974

    Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7662408

    Sustained-release preparations

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7659267

    1,3-Benzothiazinone derivatives, process for producing the same use thereof

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7652133

    Indole compound

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7649001

    Fused benzene derivative and use

    Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7642275

    Histone deacetylase inhibitors

    Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7642253

    Histone deacetylase inhibitors

    Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7638638

    Dipeptidyl peptidase inhibitors

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7625696

    Screening method

    Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7625887

    Receptor agonists

    Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7625869

    Metastin derivatives and use thereof

    Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7622487

    Piperidine derivative, process for producing the same, and use

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7622479

    Bicyclic derivative, its production and use

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7612064

    Sulfopyrroles

    Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7608409

    Screening assay using G-protein coupled receptor protein OT7T175

    Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7608627

    6-azaindole compound

    Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7601868

    Amine derivative

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7595333

    Agent for improving acidosis

    Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7592453

    Fused quinoline derivative and use thereof

    Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7585880

    Phenylpropanoic acid derivatives

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7582651

    Pyrrolopyridine derivative and use thereof

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7582662

    Body weight gain inhibitor

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7579357

    Dipeptidyl peptidase inhibitors

    Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7572574

    Method of measuring neprilysin activity

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7572920

    Benzimidazole derivative and use as a II receptor antagonist

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7572914

    Kinase inhibitors

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7569697

    Benzimidazole compound crystal

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7569570

    Thienopyrimidines, process for preparing the same and use thereof

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7569696

    Process for producing crystal

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7556926

    Methods for screening insulin-sensitizing agents

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7553867

    Furan or thiophene derivative and medicinal use thereof

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7550590

    Dipeptidyl peptidase inhibitors

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7550598

    Kinase inhibitors

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7541478

    Coumarin derivative and use thereof

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7538133

    Benzimidazole derivatives, their production and use

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7538125

    Pharmaceutical composition

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7534887

    Thiazoline derivative and use of the same

    Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7521545

    Azo compounds and process for production thereof

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7517661

    Methods of screening for ligands for FPRL2

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.